StemSpine uses a patient’s own bone marrow aspirate to treat pain, according to a news release.
The study examined 15 patients between the ages of 38 and 71 who underwent the patented procedure. The procedure was safe for all patients, and 13 of the 15 still displayed durable results after two years. Researchers measured pain scores with the Oswestry Disability Index and Visual Analogue Scale.
“To our knowledge, this is the first demonstration of the clinical efficacy of injecting bone marrow aspirate into areas surrounding the disc, which may repair, remodel and improve the blood supply around the disc and lower back area,” Creative Medical Technology president and CEO Timothy Warbington said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
